 James Orth
Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Cycle | 7 | 2018 | 598 | 1.430 |
Why?
| | Karyopherins | 2 | 2018 | 20 | 1.060 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2018 | 207 | 0.950 |
Why?
| | Cell Tracking | 2 | 2016 | 18 | 0.940 |
Why?
| | Mitosis | 6 | 2011 | 193 | 0.860 |
Why?
| | Hydrazines | 3 | 2018 | 37 | 0.720 |
Why?
| | DNA Damage | 2 | 2017 | 437 | 0.700 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2018 | 534 | 0.680 |
Why?
| | Triazoles | 3 | 2018 | 187 | 0.650 |
Why?
| | Antineoplastic Agents | 7 | 2018 | 2214 | 0.590 |
Why?
| | Cell Cycle Checkpoints | 3 | 2018 | 97 | 0.580 |
Why?
| | Apoptosis | 5 | 2018 | 2440 | 0.560 |
Why?
| | Antimitotic Agents | 4 | 2011 | 8 | 0.520 |
Why?
| | Proteasome Endopeptidase Complex | 3 | 2025 | 155 | 0.510 |
Why?
| | Endocytosis | 3 | 2006 | 168 | 0.490 |
Why?
| | Time-Lapse Imaging | 1 | 2016 | 21 | 0.480 |
Why?
| | Tubulin Modulators | 3 | 2014 | 11 | 0.470 |
Why?
| | Actins | 6 | 2026 | 425 | 0.450 |
Why?
| | Single-Cell Analysis | 3 | 2016 | 362 | 0.450 |
Why?
| | Saccharomyces cerevisiae Proteins | 3 | 2025 | 414 | 0.410 |
Why?
| | Cell Line, Tumor | 9 | 2020 | 3542 | 0.400 |
Why?
| | Cell Death | 4 | 2017 | 382 | 0.390 |
Why?
| | G1 Phase | 2 | 2026 | 65 | 0.370 |
Why?
| | Molecular Chaperones | 3 | 2025 | 199 | 0.360 |
Why?
| | Paclitaxel | 4 | 2011 | 257 | 0.360 |
Why?
| | Dynamins | 5 | 2006 | 36 | 0.360 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2020 | 934 | 0.320 |
Why?
| | Neoplasms | 9 | 2020 | 2906 | 0.310 |
Why?
| | Microscopy | 3 | 2016 | 147 | 0.280 |
Why?
| | Saccharomyces cerevisiae | 2 | 2025 | 573 | 0.270 |
Why?
| | Cell Surface Extensions | 3 | 2004 | 13 | 0.260 |
Why?
| | Cell Survival | 4 | 2018 | 1100 | 0.240 |
Why?
| | G2 Phase | 1 | 2026 | 39 | 0.240 |
Why?
| | Actin Cytoskeleton | 2 | 2026 | 103 | 0.230 |
Why?
| | ErbB Receptors | 2 | 2006 | 635 | 0.230 |
Why?
| | Cell Nucleus | 2 | 2026 | 588 | 0.230 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2026 | 325 | 0.220 |
Why?
| | Phenotype | 2 | 2015 | 3155 | 0.220 |
Why?
| | Drosophila | 1 | 2026 | 164 | 0.220 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2006 | 231 | 0.210 |
Why?
| | Immunohistochemistry | 2 | 2026 | 1716 | 0.210 |
Why?
| | Proteolysis | 2 | 2025 | 172 | 0.190 |
Why?
| | Eukaryotic Cells | 1 | 2003 | 35 | 0.190 |
Why?
| | Microfilament Proteins | 4 | 2005 | 135 | 0.190 |
Why?
| | GTP Phosphohydrolases | 1 | 2002 | 93 | 0.170 |
Why?
| | Spindle Apparatus | 3 | 2010 | 95 | 0.160 |
Why?
| | Benzoxazoles | 1 | 2020 | 20 | 0.160 |
Why?
| | Drug Resistance, Neoplasm | 4 | 2020 | 881 | 0.160 |
Why?
| | Microscopy, Fluorescence | 5 | 2014 | 408 | 0.160 |
Why?
| | Azepines | 1 | 2020 | 105 | 0.150 |
Why?
| | Cell Movement | 2 | 2003 | 959 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 67 | 0.130 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2017 | 2028 | 0.130 |
Why?
| | Imidazoles | 1 | 2018 | 247 | 0.130 |
Why?
| | Cell Lineage | 1 | 2018 | 377 | 0.120 |
Why?
| | Pyrimidines | 1 | 2020 | 530 | 0.120 |
Why?
| | HeLa Cells | 5 | 2011 | 632 | 0.120 |
Why?
| | Humans | 21 | 2026 | 145474 | 0.120 |
Why?
| | Piperazines | 1 | 2018 | 375 | 0.110 |
Why?
| | Animals | 16 | 2026 | 38030 | 0.110 |
Why?
| | Dynamin II | 2 | 2005 | 3 | 0.110 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2015 | 117 | 0.110 |
Why?
| | DNA Replication | 1 | 2017 | 249 | 0.110 |
Why?
| | Furans | 1 | 2014 | 26 | 0.110 |
Why?
| | Isoquinolines | 1 | 2014 | 43 | 0.110 |
Why?
| | Benzopyrans | 1 | 2014 | 30 | 0.110 |
Why?
| | Tetrazoles | 1 | 2014 | 50 | 0.110 |
Why?
| | Neoplasms, Experimental | 1 | 2015 | 167 | 0.100 |
Why?
| | Ketones | 1 | 2014 | 50 | 0.100 |
Why?
| | RNA Interference | 3 | 2011 | 475 | 0.100 |
Why?
| | Cortactin | 4 | 2006 | 7 | 0.100 |
Why?
| | Brain | 1 | 2026 | 2947 | 0.100 |
Why?
| | Fluorescent Dyes | 1 | 2015 | 333 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 981 | 0.100 |
Why?
| | Quinolines | 2 | 2011 | 190 | 0.100 |
Why?
| | Mice, Nude | 2 | 2014 | 679 | 0.100 |
Why?
| | Protein Binding | 2 | 2017 | 2238 | 0.090 |
Why?
| | Deoxyribonucleases | 1 | 2011 | 24 | 0.090 |
Why?
| | Mice | 8 | 2020 | 18329 | 0.090 |
Why?
| | Holoenzymes | 2 | 2022 | 25 | 0.080 |
Why?
| | Enzyme Inhibitors | 2 | 2011 | 820 | 0.080 |
Why?
| | RNA, Small Interfering | 2 | 2010 | 637 | 0.080 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1963 | 0.080 |
Why?
| | Protein Structure, Tertiary | 2 | 2003 | 855 | 0.080 |
Why?
| | Transfection | 3 | 2014 | 926 | 0.080 |
Why?
| | Amino Acid Sequence | 4 | 2006 | 2129 | 0.070 |
Why?
| | Molecular Sequence Data | 4 | 2006 | 2883 | 0.070 |
Why?
| | Cell Cycle Proteins | 2 | 2010 | 630 | 0.070 |
Why?
| | Chromosome Segregation | 1 | 2008 | 45 | 0.070 |
Why?
| | Fibroblasts | 2 | 2006 | 1025 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 3 | 2014 | 666 | 0.070 |
Why?
| | Cell Membrane | 3 | 2006 | 707 | 0.070 |
Why?
| | Cell Line | 6 | 2014 | 2823 | 0.070 |
Why?
| | Genetic Therapy | 1 | 2009 | 316 | 0.060 |
Why?
| | Genome, Human | 1 | 2009 | 420 | 0.060 |
Why?
| | Adenosine Triphosphatases | 2 | 2022 | 159 | 0.060 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2008 | 288 | 0.060 |
Why?
| | Brain Chemistry | 1 | 2026 | 119 | 0.060 |
Why?
| | COS Cells | 1 | 2006 | 177 | 0.060 |
Why?
| | Microtubules | 1 | 2008 | 265 | 0.060 |
Why?
| | Epidermal Growth Factor | 1 | 2006 | 162 | 0.060 |
Why?
| | Caveolins | 1 | 2005 | 5 | 0.060 |
Why?
| | ADP-Ribosylation Factor 1 | 1 | 2005 | 5 | 0.060 |
Why?
| | Nuclear Localization Signals | 1 | 2025 | 16 | 0.060 |
Why?
| | Green Fluorescent Proteins | 2 | 2009 | 407 | 0.060 |
Why?
| | Golgi Apparatus | 1 | 2005 | 99 | 0.050 |
Why?
| | Quality Control | 1 | 2025 | 161 | 0.050 |
Why?
| | Cryptosporidium parvum | 1 | 2004 | 13 | 0.050 |
Why?
| | Cytoplasm | 1 | 2025 | 254 | 0.050 |
Why?
| | cdc42 GTP-Binding Protein | 1 | 2004 | 21 | 0.050 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2006 | 382 | 0.050 |
Why?
| | Coated Pits, Cell-Membrane | 1 | 2003 | 3 | 0.050 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2003 | 85 | 0.050 |
Why?
| | Cell Size | 1 | 2003 | 92 | 0.050 |
Why?
| | Cytoskeletal Proteins | 1 | 2003 | 156 | 0.050 |
Why?
| | Rats | 4 | 2005 | 5584 | 0.050 |
Why?
| | Microscopy, Video | 1 | 2002 | 24 | 0.040 |
Why?
| | Models, Biological | 3 | 2009 | 1764 | 0.040 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2002 | 49 | 0.040 |
Why?
| | Phosphorylation | 1 | 2006 | 1707 | 0.040 |
Why?
| | Proline | 1 | 2002 | 82 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2008 | 2507 | 0.040 |
Why?
| | Luminescent Proteins | 1 | 2002 | 186 | 0.040 |
Why?
| | Plasmids | 1 | 2002 | 373 | 0.040 |
Why?
| | Hepatocytes | 1 | 2002 | 224 | 0.040 |
Why?
| | Histones | 1 | 2026 | 666 | 0.040 |
Why?
| | Cdc20 Proteins | 2 | 2010 | 4 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2004 | 591 | 0.040 |
Why?
| | Aurora Kinase A | 1 | 2020 | 61 | 0.040 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 1 | 2020 | 62 | 0.040 |
Why?
| | Maximum Tolerated Dose | 1 | 2020 | 210 | 0.040 |
Why?
| | RNA | 1 | 2026 | 910 | 0.040 |
Why?
| | Time Factors | 3 | 2009 | 7123 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2022 | 500 | 0.040 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2020 | 138 | 0.040 |
Why?
| | Microscopy, Confocal | 2 | 2014 | 319 | 0.040 |
Why?
| | Mutation | 3 | 2009 | 4075 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2015 | 779 | 0.030 |
Why?
| | Adenine | 1 | 2020 | 339 | 0.030 |
Why?
| | Pancreatic Neoplasms | 1 | 2006 | 928 | 0.030 |
Why?
| | Models, Molecular | 1 | 2022 | 1598 | 0.030 |
Why?
| | Neurons | 1 | 2026 | 1649 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2015 | 1443 | 0.030 |
Why?
| | Signal Transduction | 2 | 2006 | 5216 | 0.030 |
Why?
| | Microscopy, Immunoelectron | 2 | 2005 | 43 | 0.030 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2014 | 112 | 0.030 |
Why?
| | Microinjections | 2 | 2005 | 92 | 0.030 |
Why?
| | Macromolecular Substances | 2 | 2005 | 216 | 0.020 |
Why?
| | Drug Carriers | 1 | 2014 | 136 | 0.020 |
Why?
| | Cytoskeleton | 2 | 2003 | 192 | 0.020 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2011 | 11 | 0.020 |
Why?
| | HL-60 Cells | 1 | 2011 | 30 | 0.020 |
Why?
| | Bcl-2-Like Protein 11 | 1 | 2011 | 37 | 0.020 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2011 | 74 | 0.020 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2011 | 187 | 0.020 |
Why?
| | Cyclin B1 | 1 | 2009 | 5 | 0.020 |
Why?
| | Nocodazole | 1 | 2009 | 17 | 0.020 |
Why?
| | Cyclin B | 1 | 2009 | 15 | 0.020 |
Why?
| | Mitochondrial Membranes | 1 | 2009 | 40 | 0.020 |
Why?
| | Permeability | 1 | 2009 | 169 | 0.020 |
Why?
| | Blotting, Western | 1 | 2011 | 1179 | 0.020 |
Why?
| | Transcriptome | 1 | 2015 | 1038 | 0.020 |
Why?
| | HT29 Cells | 1 | 2008 | 37 | 0.020 |
Why?
| | Nanoparticles | 1 | 2014 | 517 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 239 | 0.020 |
Why?
| | HCT116 Cells | 1 | 2008 | 76 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 1 | 2011 | 624 | 0.020 |
Why?
| | Caspases | 1 | 2008 | 233 | 0.020 |
Why?
| | Epithelial Cells | 2 | 2004 | 1131 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2009 | 471 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2008 | 886 | 0.020 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2005 | 45 | 0.010 |
Why?
| | Caveolin 1 | 1 | 2005 | 20 | 0.010 |
Why?
| | Models, Statistical | 1 | 2009 | 671 | 0.010 |
Why?
| | Peptide Mapping | 1 | 2005 | 62 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2011 | 1164 | 0.010 |
Why?
| | Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2004 | 1 | 0.010 |
Why?
| | Drug Delivery Systems | 1 | 2008 | 381 | 0.010 |
Why?
| | Wiskott-Aldrich Syndrome | 1 | 2004 | 5 | 0.010 |
Why?
| | Osteoclasts | 1 | 2004 | 54 | 0.010 |
Why?
| | Pseudopodia | 1 | 2004 | 27 | 0.010 |
Why?
| | Biliary Tract Diseases | 1 | 2004 | 33 | 0.010 |
Why?
| | Cryptosporidiosis | 1 | 2004 | 22 | 0.010 |
Why?
| | rho GTP-Binding Proteins | 1 | 2004 | 56 | 0.010 |
Why?
| | Protein Transport | 1 | 2005 | 442 | 0.010 |
Why?
| | Actin-Related Protein 3 | 1 | 2003 | 1 | 0.010 |
Why?
| | Clathrin | 1 | 2003 | 26 | 0.010 |
Why?
| | Host-Parasite Interactions | 1 | 2004 | 110 | 0.010 |
Why?
| | Transferrin | 1 | 2003 | 50 | 0.010 |
Why?
| | src Homology Domains | 1 | 2003 | 35 | 0.010 |
Why?
| | Endoplasmic Reticulum | 1 | 2005 | 264 | 0.010 |
Why?
| | Dextrans | 1 | 2003 | 84 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2003 | 273 | 0.010 |
Why?
| | Lipoproteins, LDL | 1 | 2003 | 119 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2003 | 563 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2008 | 1767 | 0.010 |
Why?
| | Aged | 1 | 2020 | 26153 | 0.010 |
Why?
| | Female | 2 | 2020 | 78844 | 0.010 |
Why?
| | Middle Aged | 1 | 2020 | 36215 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2005 | 4148 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 1505 | 0.010 |
Why?
| | Liver | 1 | 2003 | 1896 | 0.010 |
Why?
| | Male | 1 | 2020 | 72842 | 0.010 |
Why?
|
|
Orth's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|